Roni Mamluk

2019

In 2019, Roni Mamluk earned a total compensation of $698K as President and Chief Executive Officer at Ayala Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$56,940
Salary$248,784
Stock Awards$307,447
Other$84,843
Total$698,014

Mamluk received $307.4K in stock awards, accounting for 44% of the total pay in 2019.

Mamluk also received $56.9K in non-equity incentive plan, $248.8K in salary and $84.8K in other compensation.

Rankings

In 2019, Roni Mamluk's compensation ranked 10,697th out of 13,971 executives tracked by ExecPay. In other words, Mamluk earned more than 23.4% of executives.

ClassificationRankingPercentile
All
10,697
out of 13,971
23rd
Division
Manufacturing
4,330
out of 5,701
24th
Major group
Chemicals And Allied Products
1,683
out of 2,200
24th
Industry group
Drugs
1,440
out of 1,886
24th
Industry
Biological Products, Except Diagnostic Substances
320
out of 389
18th
Source: SEC filing on April 27, 2021.

Mamluk's colleagues

We found two more compensation records of executives who worked with Roni Mamluk at Ayala Pharmaceuticals in 2019.

2019

Gary Gordon

Ayala Pharmaceuticals

Chief Medical Officer

2019

Yossi Maimon

Ayala Pharmaceuticals

Chief Financial Officer

News

You may also like